What Is Rosacea?
Rosacea is a chronic inflammatory skin condition primarily affecting the central face — the cheeks, nose, chin, and forehead — characterized by persistent redness, visible blood vessels, episodic flushing, and in some subtypes, inflammatory papules and pustules that resemble acne. Despite this superficial resemblance to acne, rosacea has a fundamentally different pathophysiology and requires a completely different treatment approach.
The condition is classified into four clinical subtypes by the National Rosacea Society, though significant overlap exists and many patients present with features from multiple categories. Subtype 1 (erythematotelangiectatic) is defined by flushing, persistent central redness, and visible vessels. Subtype 2 (papulopustular) adds inflammatory lesions. Subtype 3 (phymatous) involves tissue overgrowth, most commonly of the nose (rhinophyma). Subtype 4 (ocular) affects the eyes and eyelids with dryness, burning, and recurrent styes.
Rosacea affects all skin tones, though it is frequently underdiagnosed in people with darker complexions because the redness component is less visible. On medium-to-deep skin tones, rosacea more commonly presents as burning or stinging sensations, papules, and inflammatory plaques, without the obvious erythema that tends to anchor diagnosis in lighter-skinned patients.
Three Mechanisms, One Condition
To understand why rosacea behaves the way it does — and why certain skincare choices make it dramatically worse — you need to understand the three systems involved.
Neurovascular dysregulation. Rosacea skin has an abnormally reactive vascular network. The transient receptor potential (TRP) channels in facial nerve endings — particularly TRPV1 and TRPA1 — are sensitized and respond to heat, spicy food, alcohol, and emotional stress with exaggerated vasodilation. This produces the characteristic flushing response. Over time, repeated vasodilation damages the structural support around blood vessel walls, leading to permanently dilated telangiectasias. Azelaic acid and topical brimonidine (a vasoconstrictor) work at this layer of the condition.
Innate immune dysregulation. The antimicrobial peptide LL-37 — a cathelicidin — is produced at 10 times normal concentrations in rosacea-affected skin. In healthy skin, LL-37 provides antimicrobial defense; in rosacea, the abnormally high concentrations trigger inflammatory signaling that recruits neutrophils, activates mast cells, and promotes angiogenesis (new blood vessel growth). The mite Demodex folliculorum, which colonizes facial follicles in significantly higher numbers in rosacea patients, appears to amplify this innate immune response — likely through bacterial endosymbionts it carries.
Barrier dysfunction. Rosacea skin consistently shows elevated transepidermal water loss compared to unaffected skin. Ceramide analysis of rosacea-affected tissue reveals decreased levels of ceramides 1, 3, and 6 — the same deficit observed in eczema. The result is a barrier that is both water-permeable and more susceptible to irritant penetration. This explains why rosacea patients often describe their skin as "sensitive to everything" — the barrier is structurally unable to block the irritants that normal skin handles without reaction.
The Rosacea Trigger Hierarchy
Not all triggers are equal. Research consistently identifies a core group of high-impact triggers affecting the majority of rosacea patients, and a second tier of less universal but still significant triggers.
The highest-impact triggers, reported by more than 50% of rosacea patients in survey data, are: sun exposure (UV radiation drives both LL-37 production and vascular reactivity), heat and hot beverages, alcohol (especially red wine, due to histamine and tannin content), and spicy food containing capsaicin (which directly activates TRPV1 channels).
The second tier includes strenuous exercise, emotional stress, cosmetic products containing alcohol or fragrance, wind and cold, and certain topical skincare actives — particularly high-concentration niacinamide (above 5%), retinol (particularly at the start of use), and alpha hydroxy acids used at clinical pH levels.
A note on niacinamide: at concentrations of 2–4%, niacinamide is actually beneficial for rosacea, offering anti-inflammatory and barrier-strengthening effects. The "niacinamide causes flushing" concern derives from early studies on high-dose oral nicotinic acid — not topical niacinamide. However, some rosacea patients are sensitive to concentrations above 5%, where niacin conversion can be significant. Starting at a lower percentage is a reasonable precaution.
Building a Rosacea-Appropriate Skincare Routine
The guiding principle for rosacea skincare is doing less, more consistently. The barrier is compromised, the vascular and immune systems are hyperreactive, and the temptation to layer multiple actives in search of improvement is a reliable path to a flare.
Cleansing. Use lukewarm water only — never hot. Choose a gentle, non-foaming cleanser with a pH between 5 and 6 and no fragrance, alcohol, or physical exfoliating particles. The product contact time should be under 30 seconds. Pat dry; do not rub.
Moisturising. A ceramide-dominant emollient applied immediately after cleansing addresses the barrier deficit that drives sensitivity. Look specifically for products that contain ceramides, cholesterol, and fatty acids in combination rather than a single lipid class. Products with anti-inflammatory actives like centella asiatica, bisabolol, or green tea polyphenols can offer additional benefit without the risk of irritation from prescription-strength agents.
Sun protection — non-negotiable. UV is the single highest-impact rosacea trigger. A mineral sunscreen with zinc oxide or titanium dioxide (SPF 30 or higher) applied every morning is the single most impactful routine step. Chemical UV filters — particularly oxybenzone and avobenzone — cause stinging and flushing in a significant proportion of rosacea patients and should be avoided in favour of mineral filters.
Active ingredients — proceed very slowly. If adding any active (niacinamide, azelaic acid, retinoids, antioxidants), introduce one at a time, at the lowest available concentration, every third day before increasing frequency. Azelaic acid 15% (Finacea) and 20% (Skinoren) is the most evidence-backed topical active specifically for rosacea inflammatory lesions and is generally well tolerated, though an initial tingling is common.
Product Framework for Rosacea Skin
A functional rosacea routine can be built around four products: a gentle cleanser, a ceramide moisturiser, a mineral SPF, and a targeted active for inflammatory lesions. More than this introduces unnecessary exposure to potential triggers.
